This is consistent with high Ki67 staining and the number of tumor-initiating cells by limiting dilution assays observed in MMTV-HER2/MMTV-MED1 tumors compared to that of MMTV-HER2 tumors after the treatment. The gene discussed is ERBB2; the disease is neoplasm.